ArticleBMC biology2025
GraphGIM: rethinking molecular graph contrastive learning via geometry image modeling.
Article in BMC biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundLearning molecular representations is crucial for accurate drug discovery. Using graphs to represent molecules is a popular solution, and many researchers have used contrastive learning to improve the generalization of molecular graph representations.
resultsIn this work, we revisit existing graph-based contrastive methods and find that these methods have limited diversity in the constructed sample pairs, resulting in insufficient performance gains. To alleviate the above challenge, we propose a novel molecular graph contrastive learning method via geometry image modeling, called GraphGIM, which enhances the diversity between sample pairs. GraphGIM is pre-trained on 2 million 2D graphs and multi-view 3D geometry images through contrastive learning. Furthermore, we find that as the convolutional layers process the image becomes deeper, the information of feature maps gradually changes from global molecular-level information (molecular scaffolds) to local atomic-level information (molecular atoms and functional groups), which provides chemical information at different scales. Therefore, we propose two variants of GraphGIM, called GraphGIM-M and GraphGIM-P, which fuse feature maps of different scales in the image using a weighted strategy and a prompt-based strategy, respectively.
conclusionsExtensive experiments show that GraphGIM and its two variants outperform state-of-the-art graph contrastive learning methods on eight molecular property prediction benchmarks from MoleculeNet and achieve competitive results with state-of-the-art methods. The code is available at https://github.com/cyli029/GraphGIM .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.